Speakers

We’re mixing things up this week! In honor of the long Memorial Day weekend, there won’t be a traditional Friday morning Rotary meeting.

Instead, join your fellow Rotarians for a relaxed social hour—grab a drink and connect at The Daily. It’s the perfect chance to unwind, catch up, and enjoy some great company.

GLP-1 receptor agonists have received significant public attention in recent years, particularly for weight loss. However, these medications have been used for more than twenty years for the treatment of type 2 diabetes and have been studied extensively. Over the past decade, certain GLP-1 medications have also received FDA approval for weight loss, cardiovascular disease and sleep apnea. There are currently active studies for the GLP-1s preventing Alzheimer's disease, Parkinson's, Fatty Liver Disease, Substance Abuse, PCOS and inflammation. This presentation will provide an overview of how GLP-1 medications work, current approved uses, emerging research, and their potential impact on long-term health and quality of life. 

https://www.resultswellnessandweightloss.com/ 

https://ucomontana.com/